FONT-SIZE Plus   Neg

Spectrum Pharma Q4 Profit Up - Quick Facts

Spectrum Pharmaceuticals, Inc. (SPPI) reported fourth-quarter profit of $8.28 million or $0.13 per share versus $4.44 million or $0.08 per share last year.

Adjusted earnings per share were up to $0.24 from $0.19 in the same quarter last year.

On average, five analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share. Analysts' estimates typically exclude special items.

Total revenues grew to $52.98 million from $33.95 million in the prior-year quarter. Analysts estimated revenues of $52.73 million.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade SPPI now with 
Follow RTT